The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD).
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics.
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on dia...
The Global Fund is organizing a Global Health Supply Chain Dialogue from 29 to 31 March 2022 under the theme “Building Resilient Supply Chains for Effective Pandemic Preparedness”.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website.
To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.